Exonate
Pre-clinicalA biopharmaceutical company developing eyedrop treatment for Age Related Macular Degeneration wet AMD using VEGF alternative splicing.
Founded
2013
Focus
Small Molecules
About
A biopharmaceutical company developing eyedrop treatment for Age Related Macular Degeneration wet AMD using VEGF alternative splicing.
Funding History
2Total raised: $28.2M
Series A$25MSR OneSep 15, 2021
Seed$3.2MUndisclosedApr 15, 2018
Company Info
TypePrivate
Founded2013
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile